BriaCell Opens Fourth Clinical Site in Advanced Breast Cancer
BriaCell Therapeutics Corp. ("BriaCell"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce the opening of a new clinical site, Jefferson Breast Care Center in Philadelphia, PA, and the appointment of Dr. Saveri Bhattacharya, a board certified medical oncologist, as the clinical site’s principal investigator.
Saveri Bhattacharya, DO, currently Assistant Professor of Medical Oncology at Thomas Jefferson University, is a board certified oncologist experienced in clinical trials for breast cancer patients. She graduated from Touro University College of Osteopathic Medicine in 2011, and completed her Fellowship in Hematology & Oncology at the University of Pittsburgh Medical Center.
Copyright 2005 - 2019, Touro University, All Rights Reserved.